These results establish a key role of eIF4B in Abl tumorigenesis by integrating the functions of oncogenic Pim and Akt signaling pathways, and highlight eIF4B as a novel therapeutic target for Abl positive cancers. The gene discussed is ABL1; the disease is cancer.